Celldex Therapeutics, Inc.
Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Hampton, NJ
CLDX chart
What traders are saying about $CLDX
Latest postsCelldex Therapeutics, Inc. news
- Canaccord Genuity maintains Celldex Therapeutics at Buy, raises price target to $68 from $60
TradingView ·
- Morgan Stanley maintains Celldex Therapeutics at Overweight, raises price target to $61 from $57
TradingView ·
- Celldex Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $29 to $68
Moomoo ·
- Why Celldex Therapeutics (CLDX) Is Up 5.7% And What's Next
Simply Wall St ·
- Celldex Stock In Focus After Earnings Loss And Shelf Filing
Yahoo Finance ·
- Celldex Therapeutics Inc (TCE2.MU) Seasonal returns chart
Yahoo Finance UK ·
- Celldex Therapeutics earnings beat by $0.06, revenue fell short of estimates
Investing.com Australia ·
- Is Celldex Therapeutics (CLDX) Undervalued On Its Latest Earnings Report?
Simply Wall St ·
- Form S-3ASR Celldex Therapeutics Inc For: 6 November By Investing.com
Investing.com Nigeria ·
- Celldex: Q3 Earnings Snapshot
Yahoo Finance ·
- Celldex Therapeutics 3Q 2026: Revenue $0, EPS ($0.96) — 10-Q Summary
TradingView ·
Celldex Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.5M | $7.0M | $6.9M | $2.4M |
| Net income | -$258.8M | -$157.9M | -$141.4M | -$112.3M |
| Diluted EPS | $-3.90 | $-2.45 | $-2.92 | $-2.40 |
| Total assets (year end) | $583.0M | $792.3M | $465.6M | $352.7M |
| Cash and equivalents (year end) | $28.9M | $28.4M | $34.8M | $29.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Celldex Therapeutics, Inc.
- Ticker
- CLDX (Nasdaq)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Hampton, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 744218
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
Frequently asked questions
What exchange is Celldex Therapeutics, Inc. listed on?
Celldex Therapeutics, Inc. trades on the Nasdaq under the ticker symbol CLDX.
What industry is Celldex Therapeutics, Inc. in?
Celldex Therapeutics, Inc. is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is Celldex Therapeutics, Inc. headquartered?
Celldex Therapeutics, Inc.'s business address on file with the SEC is in Hampton, NJ.
When does Celldex Therapeutics, Inc.'s fiscal year end?
Celldex Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Celldex Therapeutics, Inc. report?
Celldex Therapeutics, Inc. reported $1.5M in revenue for calendar year 2025, according to its SEC filings.